In Orai3-overexpressing breast cancer cells, NEDD4L mediates the ubiquitination and degradation of its target proteins (including either p53 regulators or p53), inducing resistance to chemotherapy (Hasna et al., 2018). The gene discussed is TP53; the disease is breast cancer.